0.8505
price down icon7.22%   -0.0662
after-market Handel nachbörslich: .89 0.0395 +4.64%
loading
Schlusskurs vom Vortag:
$0.9167
Offen:
$0.9012
24-Stunden-Volumen:
108.48K
Relative Volume:
0.95
Marktkapitalisierung:
$11.39M
Einnahmen:
$52.16M
Nettoeinkommen (Verlust:
$-48.60M
KGV:
-0.1969
EPS:
-4.32
Netto-Cashflow:
$-77.48M
1W Leistung:
-29.12%
1M Leistung:
-39.68%
6M Leistung:
-79.26%
1J Leistung:
-88.94%
1-Tages-Spanne:
Value
$0.8151
$0.9445
1-Wochen-Bereich:
Value
$0.8151
$1.24
52-Wochen-Spanne:
Value
$0.8151
$10.50

Hookipa Pharma Inc Stock (HOOK) Company Profile

Name
Firmenname
Hookipa Pharma Inc
Name
Telefon
0114318906360
Name
Adresse
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY
Name
Mitarbeiter
0
Name
Twitter
@HookipaPharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
HOOK's Discussions on Twitter

Vergleichen Sie HOOK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HOOK
Hookipa Pharma Inc
0.8505 11.39M 52.16M -48.60M -77.48M -4.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 125.55B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 67.78B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 36.24B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.99B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.77B 3.81B -644.79M -669.77M -6.24

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-20 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-11-15 Bestätigt RBC Capital Mkts Outperform
2022-12-02 Herabstufung BofA Securities Buy → Underperform
2021-11-12 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-04-08 Eingeleitet Morgan Stanley Overweight
2020-11-03 Eingeleitet Truist Buy
2020-10-26 Eingeleitet JMP Securities Mkt Outperform
2020-10-19 Fortgesetzt H.C. Wainwright Buy
2019-09-27 Eingeleitet H.C. Wainwright Buy
2019-05-13 Eingeleitet BofA/Merrill Buy
2019-05-13 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Hookipa Pharma Inc Aktie (HOOK) Neueste Nachrichten

pulisher
Mar 31, 2025

Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India

Mar 31, 2025
pulisher
Mar 21, 2025

Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 16, 2025

HOOKIPA Pharma to participate in upcoming investor conferences in September - MarketScreener

Mar 16, 2025
pulisher
Mar 13, 2025

Hookipa Pharma (HOOK) Expected to Announce Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 06, 2025

Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline - Investing.com Australia

Mar 06, 2025
pulisher
Mar 05, 2025

Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Feb 28, 2025

HOOKIPA Pharma Inc. SEC 10-K Report - TradingView

Feb 28, 2025
pulisher
Feb 25, 2025

Hookipa Pharma stock hits 52-week low at $1.56 amid downturn - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Hookipa Pharma stock hits 52-week low at $1.56 amid downturn By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 23, 2025

Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN

Feb 23, 2025
pulisher
Feb 21, 2025

BRIEF—Proposed combination of Poolbeg with HOOKIPA called off - The Pharma Letter

Feb 21, 2025
pulisher
Feb 21, 2025

HOOKIPA Pharma ends talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Poolbeg slumps as Hookipa merger is called off - pharmaphorum

Feb 21, 2025
pulisher
Feb 21, 2025

Hookipa Pharma (NASDAQ:HOOK) Shares Down 4.8% – Time to Sell? - Defense World

Feb 21, 2025
pulisher
Feb 21, 2025

Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA - Share Talk

Feb 21, 2025
pulisher
Feb 21, 2025

Poolbeg merger off after HOOKIPA ends discussions - Proactive Investors

Feb 21, 2025
pulisher
Feb 21, 2025

Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger - TradingView

Feb 21, 2025
pulisher
Feb 21, 2025

HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewswire

Feb 21, 2025
pulisher
Feb 20, 2025

HOOKIPA Pharma ends talks to acquire Poolbeg Pharma - Investing.com India

Feb 20, 2025
pulisher
Feb 20, 2025

Failed Merger: Why HOOKIPA Pharma Walked Away from Poolbeg Deal - StockTitan

Feb 20, 2025
pulisher
Feb 12, 2025

Hookipa Pharma stock hits 52-week low at $1.71 amid downturn - MSN

Feb 12, 2025
pulisher
Jan 31, 2025

Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial - Yahoo Finance

Jan 31, 2025
pulisher
Jan 31, 2025

Hookipa Pharma Files Petition to Validate Stockholder Actions at Annual Meetings - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

HOOKIPA completes enrollment for HIV vaccine trial By Investing.com - Investing.com Nigeria

Jan 30, 2025
pulisher
Jan 30, 2025

HOOKIPA Pharma seeks court validation for stockholder actions By Investing.com - Investing.com Australia

Jan 30, 2025
pulisher
Jan 30, 2025

HOOKIPA completes enrollment for HIV vaccine trial - Investing.com India

Jan 30, 2025
pulisher
Jan 30, 2025

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b - GlobeNewswire

Jan 30, 2025
pulisher
Jan 30, 2025

Game-Changing HIV Vaccine Trial Fully Enrolled: HOOKIPA's Path to Potential Cure - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment… - Informazione.it

Jan 30, 2025
pulisher
Jan 30, 2025

Poolbeg Agrees to Bid Deadline Extension for Possible Hookipa Pharma Deal - MarketWatch

Jan 30, 2025
pulisher
Jan 30, 2025

Poolbeg Pharma granted extension to PUSU Deadline - DirectorsTalk Interviews

Jan 30, 2025
pulisher
Jan 30, 2025

Poolbeg and HOOKIPA given more time to agree merger deal - Proactive Investors USA

Jan 30, 2025
pulisher
Jan 30, 2025

Poolbeg Pharma PLC (AIM:POLB) Offer Update – Extension to PUSU Deadline - Share Talk

Jan 30, 2025
pulisher
Jan 30, 2025

Poolbeg Pharma and HOOKIPA Extend Merger Deadline Amid Positive Discussions - TipRanks

Jan 30, 2025
pulisher
Jan 29, 2025

HOOKIPA Pharma seeks court validation for stockholder actions - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

Hookipa Pharma Seeks Validation for Stockholder Meetings - TipRanks

Jan 29, 2025
pulisher
Jan 19, 2025

HOOK (HOOKIPA Pharma) Shares Outstanding (EOP) : 12.05 Mil (As of Sep. 2024) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 14, 2025

Hookipa Pharma stock hits 52-week low at $1.73 amid market challenges - Investing.com Nigeria

Jan 14, 2025

Finanzdaten der Hookipa Pharma Inc-Aktie (HOOK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):